Evidence map›Paper›PMID 33562714›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Methyl Jasmonate and Methyl-β-Cyclodextrin Individually Boost Triterpenoid Biosynthesis in

Audrey S Commault, Unnikrishnan Kuzhiumparambil, Andrei Herdean, Michele Fabris, Ana Cristina Jaramillo-Madrid, Raffaela M Abbriano, Peter J Ralph, Mathieu Pernice

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Promoting Photosynthetic Production of Dammarenediol-II inInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Audrey S CommaultClimate Change Cluster, University of Technology Sydney, Ultimo, NSW 2007, Australia.ORCID 0000-0002-6730-0089
Unnikrishnan KuzhiumparambilClimate Change Cluster, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Andrei HerdeanClimate Change Cluster, University of Technology Sydney, Ultimo, NSW 2007, Australia.ORCID 0000-0003-2143-0213
Michele FabrisClimate Change Cluster, University of Technology Sydney, Ultimo, NSW 2007, Australia.ORCID 0000-0003-2910-2089
Ana Cristina Jaramillo-MadridClimate Change Cluster, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Raffaela M AbbrianoClimate Change Cluster, University of Technology Sydney, Ultimo, NSW 2007, Australia.ORCID 0000-0002-5754-5461
Peter J RalphClimate Change Cluster, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Mathieu PerniceClimate Change Cluster, University of Technology Sydney, Ultimo, NSW 2007, Australia.ORCID 0000-0002-3431-2104
University of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The commercialisation of valuable plant triterpenoids faces major challenges, including low abundance in natural hosts and costly downstream purification procedures. Endeavours to produce these compounds at industrial scale using microbial systems are gaining attention. Here, we report on a strategy to enrich the biomass of the biotechnologically-relevant

Indexed as

elicitorsmicroalgaenatural productsqualenesteroltriterpeneswhite biotechnology

Identifiers

PMID33562714
PMCPMC7915139
OpenAlexW3127616674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.